A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis

Stopped after interim analysis it was determined that the risks were too great in comparision to the results

Conditions

• Peritoneal Neoplasms

Interventions

• PROCEDURE: Surgical debulking with peritonectomy
• DRUG: Intraperitoneal 5FU
• DRUG: FOLFOX

Sponsor

Washington University School of Medicine